Captrust Financial Advisors Vbi Vaccines Inc Transaction History

Captrust Financial Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.29 - $0.64 $2,316 - $5,112	-7,988 Reduced 1.47%	536,130 $160,000
Q4 2022 Feb 15, 2023	SELL	$0.38 - $22.5 $21,930 - $1.3 Million	-57,712 Reduced 9.59%	544,118 $212,000
Q3 2022 Nov 16, 2022	BUY	$0.73 - $23.4 $439,314 - $14.1 Million	601,800 Added 2006000.0%	601,830 $425,000
Q4 2021 Feb 14, 2022	SELL	$2.21 - $3.22 $254,083 - $370,203	-114,970 Reduced 99.97%	30 $0
Q4 2020 Feb 16, 2021	BUY	$2.15 - $3.5 $246,820 - $401,800	114,800 Added 57400.0%	115,000 $316,000
Q3 2020 Nov 17, 2020	BUY	$2.77 - $6.17 $554 - $1,234	200 New	200 $1,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.